ASCO’s CancerLinQ® has launched the SmartLinQ™ QOPI® Certification Pathway, an application that empowers oncology practices to automate quality measure tracking and reporting for participation in ASCO’s Quality Oncology Practice Initiative (QOPI) Certification Program, a 3-year certification recognizing practices’ commitment to high-quality care for outpatient oncology practices.
The new SmartLinQ QOPI Certification Pathway was piloted at four of CancerLinQ’s subscribing practices, enabling them to reduce staff time and expenses for quality reporting for QOPI Certification. It is now available for recertification and maintenance submissions for all QOPI Certified CancerLinQ subscribers.
SmartLinQ’s benefits stem from the automation of quality management functions—beginning with data collection. CancerLinQ automatically and securely takes in, harmonizes, and codifies the data from practices’ electronic health records (EHR) systems, eliminating the need for manual chart abstraction for quality programs like QOPI Certification. New Mexico Cancer Center, one of the SmartLinQ QOPI Certification Pathway pilot practices, saved approximately 100 hours of staff time when using SmartLinQ to automate its recertification for the QOPI Certification Program.
Beyond data abstraction and automated quality reporting for QOPI Certification, SmartLinQ enables practices to:
“With electronic reporting, things are seamless,” said Luis A. Rojas, MD, FACOG Clinical Vice President of Cancer Services at Avera Cancer Institute, a SmartLinQ pilot practice in Sioux Falls, South Dakota. “It’s actually gratifying to the physicians when we see our numbers.”
Luis A. Rojas, MD, FACOG
CancerLinQ® and SmartLinQ™ are products of CancerLinQ, LLC. The QOPI® Certification Program is a program of QOPI Certification Program, LLC, a wholly owned subsidiary of American Society of Clinical Oncology, Inc. For more information on how to participate or to schedule a demo, please visit CancerLinQ.org or email firstname.lastname@example.org.
© 2020. American Society of Clinical Oncology. All rights reserved.